Company / Capital Expenditures
Neogen Capital Expenditures History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$104.6M
FY2024
5-year range
$24.4M / $111.4M
FY2020-FY2024
Trend
-6.1%
vs FY2023
Sector context
#56 of 145
Health Care
What the data says
At $105M, Neogen's capital expenditures ranks #56 of 145 in the Health Care sector. Capital Expenditures has fluctuated over the past 9 years, ranging from $15M in FY2016 to $111M in FY2023.
Based on SEC 10-K filings.
$105M in FY2024 with a 5-year CAGR of +34.2%.
Improved from $66M to $105M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +62.4%
- 5-Year CAGR
- +34.2%
- 10-Year CAGR
- -
Sector benchmark
#56 of 145 in Health CareTop 39% of 145This company $104.6M Sector average $268.6M
▼
-61.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +34.2%, indicating consistent growth.
- In FY2024, capital expenditures decreased 6.1% year-over-year.
- Ranks #56 out of 145 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $104.6M | -6.1% |
| FY2023 | $111.4M | +69.4% |
| FY2022 | $65.8M | +169.2% |
| FY2021 | $24.4M | -8.5% |
| FY2020 | $26.7M | +11.1% |
| FY2019 | $24.1M | +64.1% |
| FY2018 | $14.7M | -30.0% |
| FY2017 | $20.9M | +43.7% |
| FY2016 | $14.6M | +2.5% |
As of FY2024 · SEC 10-K · Updated Mar 28, 2026